Activators of Alpha Synuclein Expression Identified by Reporter Cell Line-Based High Throughput Drug Screen

Scientists identified specific modulators of alpha synuclein gene (SNCA) transcription, generated CRISPR/Cas9 modified SNCA-GFP-luciferase genomic fusion- and control cell lines and screened a library of 1649 bioactive compounds, including the FDA approved drugs.